Yael Gelfand Selected Research

Activities of Daily Living (ADL)

8/2004

A novel approach for prevention of lethal GVHD by selective elimination of alloreactive donor lymphocytes prior to stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yael Gelfand Research Topics

Disease

7	Neoplasms (Cancer) 04/2009 - 03/2001
6	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2009 - 07/2004
2	Carcinoma (Carcinomatosis) 04/2009 - 03/2001
2	Residual Neoplasm 08/2008 - 02/2006
1	Hematologic Neoplasms (Hematological Malignancy) 04/2009
1	Leukemia 04/2009
1	B-Cell Leukemia (Leukemia, B Cell) 04/2009
1	Melanoma (Melanoma, Malignant) 08/2008
1	Experimental Melanoma 02/2006
1	Breast Neoplasms (Breast Cancer) 01/2002
1	Neoplasm Metastasis (Metastasis) 01/2002

Drug/Important Bio-Agent (IBA)

2	Immunologic Factors (Immunomodulators)IBA 04/2009 - 05/2007
2	Freund's AdjuvantIBA 04/2009 - 05/2007
2	Epithelial Cell Adhesion MoleculeIBA 08/2008 - 02/2006
1	incomplete Freund's adjuvantIBA 04/2009
1	Interleukin-2 (IL2)IBA 04/2009
1	OligodeoxyribonucleotidesIBA 04/2009
1	InterleukinsIBA 08/2008
1	Bispecific AntibodiesIBA 02/2006
1	AntibodiesIBA 02/2006
1	KRN 7000 (KRN7000)IBA 07/2004
1	Aligeron (AS 2)IBA 01/2002
1	AntigensIBA 03/2001

Therapy/Procedure

5	Therapeutics 09/2008 - 01/2002
3	Stem Cell Transplantation 04/2009 - 07/2004
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2004 - 03/2001
1	Transplantation 09/2008
1	Activities of Daily Living (ADL) 08/2004
1	Immunotherapy 08/2004
1	Injections 03/2001